Galenea Awarded $3 Million National Institutes of Health (NIH) Grant to Develop Translational EEG Biomarkers for Schizophrenia
9/6/2012 10:20:02 AM
More...
|
Galenea and CHDI Foundation Announce Extension and Expansion of Huntington's Disease Collaboration
8/9/2012 10:32:45 AM
More...
|
Timothy A. Ryan, PhD Joins Galenea's Scientific Advisory Board
7/16/2012 9:48:41 AM
More...
|
Galenea and Eisai Company, Ltd. (ESALY.PK) Enter into Research Collaboration to Develop Synaptic Modulators for Neurodegenerative Diseases
7/10/2012 10:20:58 AM
More...
|
Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
4/26/2012 7:50:02 AM
More...
|
Galenea Announces Publication Describing High Throughput Screening System for Modulators of Synaptic Function
10/11/2011 8:09:35 AM
More...
|
Galenea Announces Publication Describing High Throughput Screening System for Modulators of Synaptic Function
10/6/2011 12:45:42 PM
More...
|
Galenea Awarded Two SBIR Grants to Advance Innovative Approaches for the Discovery and Development of Effective Treatments for Schizophrenia
9/28/2011 10:44:04 AM
More...
|
Galenea and CHDI Foundation Announce Collaboration to Identify Key Synaptic Dysfunction in Huntington's Disease
9/6/2011 11:58:02 AM
More...
|
Galenea Awarded $4.5 Million Grant for Advancement of Innovative Synaptic Transmission Screen
10/15/2010 6:54:25 AM
More...
|
|